CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review

Author:

Curran Katie1ORCID,Whitestone Noelle2,Zabeen Bedowra3,Ahmed Munir4,Husain Lutful4,Alauddin Mohammed4,Hossain Mohammad Awlad2,Patnaik Jennifer L25,Lanouette Gabriella2,Cherwek David Hunter2,Congdon Nathan126,Peto Tunde1,Jaccard Nicolas2

Affiliation:

1. Centre for Public Health, Queens University Belfast, Belfast, UK

2. Orbis International, New York, NY, USA

3. Department of Paediatrics, Life for a Child & Changing Diabetes in Children Programme, Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine & Metabolic Disorders (BIRDEM), Diabetic Association of Bangladesh, Dhaka, Bangladesh

4. Orbis Bangladesh, Dhaka, Bangladesh

5. Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA

6. Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

Abstract

Background: Artificial intelligence (AI) appears capable of detecting diabetic retinopathy (DR) with a high degree of accuracy in adults; however, there are few studies in children and young adults. Methods: Children and young adults (3-26 years) with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) were screened at the Dhaka BIRDEM-2 hospital, Bangladesh. All gradable fundus images were uploaded to Cybersight AI for interpretation. Two main outcomes were considered at a patient level: 1) Any DR, defined as mild non-proliferative diabetic retinopathy (NPDR or more severe; and 2) Referable DR, defined as moderate NPDR or more severe. Diagnostic test performance comparing Orbis International’s Cybersight AI with the reference standard, a fully qualified optometrist certified in DR grading, was assessed using the Matthews correlation coefficient (MCC), area under the receiver operating characteristic curve (AUC-ROC), area under the precision-recall curve (AUC-PR), sensitivity, specificity, positive and negative predictive values. Results: Among 1274 participants (53.1% female, mean age 16.7 years), 19.4% (n = 247) had any DR according to AI. For referable DR, 2.35% (n = 30) were detected by AI. The sensitivity and specificity of AI for any DR were 75.5% (CI 69.7-81.3%) and 91.8% (CI 90.2-93.5%) respectively, and for referable DR, these values were 84.2% (CI 67.8-100%) and 98.9% (CI 98.3%-99.5%). The MCC, AUC-ROC and the AUC-PR for referable DR were 63.4, 91.2 and 76.2% respectively. AI was most successful in accurately classifying younger children with shorter duration of diabetes. Conclusions: Cybersight AI accurately detected any DR and referable DR among children and young adults, despite its algorithms having been trained on adults. The observed high specificity is particularly important to avoid over-referral in low-resource settings. AI may be an effective tool to reduce demands on scarce physician resources for the care of children with diabetes in low-resource settings.

Publisher

SAGE Publications

Subject

General Medicine

Reference43 articles.

1. International Diabetes Federation. IDF diabetes atlas, 10th edition. 2021. Accessed May 5, 2022. https://diabetesatlas.org/atlas/tenth-edition/

2. Diabetes in the young – a global view and worldwide estimates of numbers of children with type 1 diabetes

3. World Health Organisation. Diabetes. 2021. Accessed May 18, 2022. https://www.who.int/news-room/fact-sheets/detail/diabetes

4. The World Bank. The World Bankd in Bangladesh. 2021. Accessed May 18, 2022. https://www.worldbank.org/en/country/bangladesh/overview#1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3